ceo alex gorsky will weigh in today. exclusive, 4:00 p.m.rn. ♪ ♪ here we are, me and you ♪ on the road ♪ and we know that it goes on and on ♪ [ female announcer ] you're the boss of your life. in charge of making memories and keeping promises. ask your financial professional how lincoln financial can help you take charge of your future. ♪ ♪ oh, oh, all the way ♪ oh, oh >>> welcome >>> welcome back. if you're traveling you are bracing for delays after thousands of faa wores wekers w hit with furloughs. hampton pearson is at reagan national outside washington, d.c., with the latest developments. hampton, over to you. >> reporter: maria, we've had about a dozen flights here subject to delays of one kind or another. those outbound 45 minutes to an hour. there was one three-hour delay. in your backyard, the new york area airports, newark, laguardia and jfk have had significant delays according to, quote, staffing issues, we are told. it's the beginning of some 15,000 controllers being furloughed over the next six months. all part of those sequest

ceo alex gorsky is up next in an interview you'll only see here. the company's first quarter sales were $17.5 billion. we'll find out what he's got planned for the second quarter right after this break. stay with us. >>> >>> welcome back. johnson & johnson shares at an all-time high. 84.83 tl$84.83 a share. the company enjoyed a major boost after the potential type 2 diabetes drug was granted fda approval. let's check in on j & j. has the brand fully recovered from product recalls? ceo alex gorsky. >> great to see you almost a year later. >> a year later. when you first started, we talked a bit. let me go back to when we first tarted. i guess a year ago when we first talked, we talked a lot about those product rahmecalls. you were putting a strategy in place to ensure the trust came back to j & j, such an important name and trusted brand in the country. where are you on in strategy? >> i'm incredibly proud of all that we've done and all that the organization has accomplished. and really the people of johnson & johnson. so if you remember, when we s

but weldon left the group a year ago and he was replaced by alex gorsky who was widely viewed as therightest young star in pharma. when you get off the table and get off the desk with pharma executives, they talk lovingly about gorsky. since then, j&j has been getting the house in order. and considering that he took over a year ago, you're getting a 26.7% return. i think this move is far from finish. j&j is trading at less than 15 times earnings. the average consumer staple companies can't grow as fast as j&j when it gets its groove back. granted, j&j still has issues including the big fda mandated recall of an orthopedic device back in february and a ton of lawsuits for its artificial joints where i would say from my legal training the company have some real bad facts on its side. but that doesn't seem to put a lid on the stock. however, the company has been doing a bunch of smart things. j&j closed on the acquisition of sinthis, the walmart of medical devices, expanding the orthopedic offerings, giving them more exposure to the trauma business. j&j has a gigantic medical device pip

i'm talking about johnson & johnson, which is now run by a young bright light of executives alex gorski. my travel trust is trying to sink its teeth into a large position because this company is running. it is galloping to 100. because i fear that i will not be in for my trust and the potential for a break-up. that would drive the stocks substantially higher. don't forget, we have one more big pharma story that we're going to tell later on in the show. stay tuned. after closing tuesday we find out how badly personal computers are doing when the pitiful helpless giant intel comes out with its results. there are many conflicting reports about the semiconductor giant. with some outfits like bernstein urging you to short it. i kid you not. other firms like wells fargo saying it will be just fine. it's too cheap to avoid. tuesday we find out, and i have to say, if you think intel looks cheap now, like i do, it will be really cheap if it pulls back on its quarter. wednesday is oil day. core labs, the intellectual property behind so many oil finds that we talk about, this company is the best l

the company was so poorly managed under ceo alex gorsky's predecessor, the much lionized william wheldonat reason there's nothing but net going forward. but their management didn't get the better of the analysts. despite beating expectations in a big way their stocks did not react as shareholders hoped. for yahoo and intel they didn't beat the dead horse. the dead horse beat them. at least for now. stick with cramer. aw this is tragic man, investors just like you could lose tens of thousands of dollars on their 401(k) to hidden fees. thankfully e-trade has low cost investments and no hidden fees. but, you know, if you're still bent on blowing this fat stack of cash, there's a couple of ways you could do it. ♪ ♪ or just go to e-trade and save it. boom. ♪ since aflac is helping with his expenses while he can't work, he can focus on his recovery. he doesn't have to worry so much about his mortgage, groceries, or even gas bills. kick! kick... feel it! feel it! feel it! nice work! ♪ you got it! you got it! yes! aflac's gonna help take care of his expenses. and us...we're gonna get him back in

company, which my charitable trust proudly owns, is still being cleaned up by its brand new ceo alex gorskyso far all the big pharmas which have gone out of the way to create value, whether it's bristol myers or pfizer or schering-plough which sold itself to merck after cramer fave ceo and now author fred hassan decided there's no more value left to create. it's time for j&j to follow in the footsteps and split into the fast growing pharma business, the cash flow machine that is consumer products and the troubled but profitable medical device business. meanwhile, the company's still got that 3% yield, attractive alternative to bonds especially when you factor in the favorable tax treatment for dividends and the aaa balance sheet. if you told me that reliant tech, atk, the defense company, would be up at all considering the sequester, i would have been shocked. yes. like wichita. shocker. 16% gain. it's posted. it's completely remarkable. if you're a defense contractor, starved for growth, you can pick this stock up for a song. less than $3 billion. i think it's possible. now, we keep hearin

the notion that alex gorski can bring more value. this is a mistake, this downgrade. very worried about the quarter. i get less and less worried the more gorski gets in there and starts solving the more time. >> he solves the welden-caused problems. >> when you talk about people, gorski is the bright star. i think j & j will blow it out over the next couple of years. i like them. >> you know who's having a pretty good day is lufkin injuries. i know there are no mergers. i heard that from my partner david faber and despite the more mergers, this gain of 23 is not real, right? there was no merger today. >> that's not fair. i contend that you can't call something a merger monday unless you have a number of deals and by the way, there has been a dearth of m & a without a doubt despite the fact that my good friend here called for a significant, and perhaps even an avalanche of deal making. >> how about this? you've been completely right and i've been wrong. >> now we can move on. >> next case. next case. >> you've been right. if you missed the news, by the way, ge buying l